C
C. M. F. Kneepkens
Researcher at VU University Amsterdam
Publications - 45
Citations - 2111
C. M. F. Kneepkens is an academic researcher from VU University Amsterdam. The author has contributed to research in topics: Infliximab & Inflammatory bowel disease. The author has an hindex of 21, co-authored 45 publications receiving 1932 citations. Previous affiliations of C. M. F. Kneepkens include Université de Montréal & VU University Medical Center.
Papers
More filters
Journal ArticleDOI
The potential of the hydrocarbon breath test as a measure of lipid peroxidation
TL;DR: The results of the hydrocarbon breath test are not influenced by prior food consumption, but both vitamin E and beta-carotene supplementation decrease hydrocarbon excretion, and the long-term use of a diet high in polyunsaturated fatty acids, such as in parenteral nutrition regimens, may result in increased hydrocarbon exhalation.
Journal ArticleDOI
Management of trichobezoar: case report and literature review
Ramon R. Gorter,C. M. F. Kneepkens,E. C. J. L. Mattens,Daniel C. Aronson,Daniel C. Aronson,Hugo A. Heij +5 more
TL;DR: According to the experience and in line with the published results, conventional laparotomy is still the treatment of choice and psychiatric consultation is necessary to prevent relapses.
Journal ArticleDOI
The long-term follow-up of patients with a congenital diaphragmatic hernia: a broad spectrum of morbidity.
M. G. Peetsold,Hugo A. Heij,C. M. F. Kneepkens,A. F. Nagelkerke,Jaap Huisman,Reinoud J. B. J. Gemke +5 more
TL;DR: It has been suggested that new therapeutic modalities such as nitric oxide, high frequency oxygenation and extracorporal membrane oxygenation (ECMO) might decrease mortality associated with pulmonary hypertension and the sequelae of artificial ventilation, and that follow-up studies that systematically assess long-term sequelae are mandatory.
Journal ArticleDOI
A proposition for the diagnosis and treatment of gastro-oesophageal reflux disease in children: a report from a working group on gastro-oesophageal reflux disease
Yvan Vandenplas,A. Ashkenazi,Dominique Charles Belli,N. Boige,J. Bouquet,Samy Cadranel,J.-P. Cezard,Salvatore Cucchiara,Christophe Dupont,Karel Geboes,Frédéric Gottrand,Hugo S. A. Heymans,C. Jasinski,C. M. F. Kneepkens,S. Koletzko,Peter J. Milla,Jf. Mougenot,D. Nusslé,J. Navarro,S. J. Newell,E. Olafsdottir,S. Peeters,A. M. Ravelli,Isabel Polanco,B. K. Sandhu,Jules J. M. Tolboom +25 more
TL;DR: It is agreed that infants with uncomplicated gastro-oesophageal reflux can be safely treated before performing (expensive and often unnecessary) complementary investigations, however, the latter are mandatory if symptoms persist despite appropriate treatment.
Journal ArticleDOI
Lactose malabsorption and intolerance: a systematic review on the diagnostic value of gastrointestinal symptoms and self-reported milk intolerance
TL;DR: It is shown that high-quality studies on the diagnosis of lactose malabsorption and intolerance in primary care are urgently needed, and an important prerequisite would be to clearly define the concept of lactous intolerance.